Literature DB >> 2076395

Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction.

I Amende1, G Herrmann, R Simon, W P Hood, P Wenzlaff, P R Lichtlen.   

Abstract

To assess whether pretreatment with intracoronary nifedipine protects the myocardium against acute ischemia induced by coronary occlusion, 18 patients were studied during coronary angioplasty of the left anterior coronary artery. After a control occlusion of 60 seconds, 0.1 mg nifedipine was injected and occlusion was repeated for 60 seconds. Before and during the occlusion period, pulmonary capillary pressure was measured and the intracoronary epicardial ECG was recorded. After intracoronary administration of nifedipine, the onset of the rise in diastolic filling pressure was delayed from 23 to 38 seconds (p less than 0.01) and the changes at 60 seconds of occlusion were reduced from 14 to 11 mmHg (p less than 0.05). Nifedipine delayed the appearance of ischemic ST-segment elevation in the intracoronary ECG from 11 to 21 seconds (p less than 0.01) and diminished the changes at 60 seconds of occlusion from 1.8 to 1.2 mV (p less than 0.05). These findings suggest that pretreatment with intracoronary nifedipine protects the myocardium against some of the mechanical and electrocardiographic consequences of regional ischemia during acute coronary occlusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076395     DOI: 10.1007/BF02018287

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  15 in total

1.  The relationship between pulmonary artery wedge pressure and left atrial pressure in man.

Authors:  D C CONNOLLY; J W KIRKLIN; E H WOOD
Journal:  Circ Res       Date:  1954-09       Impact factor: 17.367

2.  Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.

Authors:  C Hanet; M F Rousseau; M F Vincent; E Lavenne-Pardonge; H Pouleur
Journal:  Am J Cardiol       Date:  1987-05-01       Impact factor: 2.778

3.  Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine?

Authors:  P W Serruys; M van den Brand; R W Brower; P G Hugenholtz
Journal:  Eur Heart J       Date:  1983-05       Impact factor: 29.983

4.  Cardiovascular protection by Ca antagonists.

Authors:  A Fleckenstein; G Fleckenstein-Grün
Journal:  Eur Heart J       Date:  1980-12       Impact factor: 29.983

5.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

Authors:  W G Nayler; R Ferrari; A Williams
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

6.  Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening.

Authors:  P D Henry; R Shuchleib; R E Clark; J E Perez
Journal:  Am J Cardiol       Date:  1979-10-22       Impact factor: 2.778

7.  Intracoronary nifedipine in human beings: magnitude and time course of changes in left ventricular contraction/relaxation and coronary sinus blood flow.

Authors:  I Amende; R Simon; W P Hood; R Hetzer; P R Lichtlen
Journal:  J Am Coll Cardiol       Date:  1983-12       Impact factor: 24.094

8.  Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.

Authors:  P D Henry; R Shuchleib; L J Borda; R Roberts; J R Williamson; B E Sobel
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

9.  Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty.

Authors:  G Pop; P W Serruys; F Piscione; P J de Feyter; M van den Brand; T Huizer; J W de Jong; P G Hugenholtz
Journal:  Int J Cardiol       Date:  1987-07       Impact factor: 4.164

10.  Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty.

Authors:  P L Friedman; T L Shook; J M Kirshenbaum; A P Selwyn; P Ganz
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

View more
  2 in total

1.  Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA.

Authors:  K Saito; H Nonogi; Y Goto; A Itoh; S Daikoku; S Miyazaki; K Haze
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

2.  Beneficial actions of amlodipine in the multiple-stunned canine myocardium.

Authors:  G J Gross; G M Pieper
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.